Skip to main content
San Francisco homeNews home
Story
9 of 27

FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs - fda.gov

FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs  fda.gov F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs  The New York Times HHS Sec. Robert F. Kennedy & FDA Commissioner Marty Makary on Drug Prices  C-SPAN FDA to speed up approvals of generic biologic medicines as Trump targets high drug costs  CNBC FDA to streamline approvals for generic biological drugs in latest move targeting health costs  CNN

Latest News